Literature DB >> 19058290

Stem cell options for kidney disease.

C Hopkins1, J Li, F Rae, M H Little.   

Abstract

Chronic kidney disease (CKD) is increasing at the rate of 6-8% per annum in the US alone. At present, dialysis and transplantation remain the only treatment options. However, there is hope that stem cells and regenerative medicine may provide additional regenerative options for kidney disease. Such new treatments might involve induction of repair using endogenous or exogenous stem cells or the reprogramming of the organ to reinitiate development. This review addresses the current state of understanding with respect to the ability of non-renal stem cell sources to influence renal repair, the existence of endogenous renal stem cells and the biology of normal renal repair in response to damage. It also examines the remaining challenges and asks the question of whether there is one solution for all forms of renal disease.

Entities:  

Mesh:

Year:  2009        PMID: 19058290     DOI: 10.1002/path.2477

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  36 in total

Review 1.  Renal organogenesis: what can it tell us about renal repair and regeneration?

Authors:  Melissa H Little
Journal:  Organogenesis       Date:  2011 Oct-Dec       Impact factor: 2.500

2.  Human amniotic fluid stem cell preconditioning improves their regenerative potential.

Authors:  Cinzia Rota; Barbara Imberti; Michela Pozzobon; Martina Piccoli; Paolo De Coppi; Anthony Atala; Elena Gagliardini; Christodoulos Xinaris; Valentina Benedetti; Aline S C Fabricio; Elisa Squarcina; Mauro Abbate; Ariela Benigni; Giuseppe Remuzzi; Marina Morigi
Journal:  Stem Cells Dev       Date:  2011-12-23       Impact factor: 3.272

Review 3.  Kidney regeneration: common themes from the embryo to the adult.

Authors:  M Cecilia Cirio; Eric D de Groh; Mark P de Caestecker; Alan J Davidson; Neil A Hukriede
Journal:  Pediatr Nephrol       Date:  2013-09-05       Impact factor: 3.714

4.  Renal tissue engineering with decellularized rhesus monkey kidneys: age-related differences.

Authors:  Karina H Nakayama; Cynthia A Batchelder; Chang I Lee; Alice F Tarantal
Journal:  Tissue Eng Part A       Date:  2011-10-18       Impact factor: 3.845

5.  Restitutio ad integrum: a dream or a real possibility?

Authors:  Michael S Goligorsky
Journal:  Nephrol Dial Transplant       Date:  2013-05-17       Impact factor: 5.992

Review 6.  Renal stem cell reprogramming: Prospects in regenerative medicine.

Authors:  Elvin E Morales; Rebecca A Wingert
Journal:  World J Stem Cells       Date:  2014-09-26       Impact factor: 5.326

Review 7.  Treatment strategies and clinical trial design in ADPKD.

Authors:  Vicente E Torres
Journal:  Adv Chronic Kidney Dis       Date:  2010-03       Impact factor: 3.620

Review 8.  Progenitor/stem cells in renal regeneration and mass lesions.

Authors:  Ping L Zhang; Jason M Hafron
Journal:  Int Urol Nephrol       Date:  2014-09-03       Impact factor: 2.370

9.  Chimeric maternal cells in offspring do not respond to renal injury, inflammatory or repair signals.

Authors:  Jesús M López-Guisa; Rebecca Howsmon; Andrew Munro; Kendall M Blair; Edward Fisher; Heidi Hermes; Richard Zager; Anne M Stevens
Journal:  Chimerism       Date:  2011-04

10.  Chimeric Allografts Induced by Short-Term Treatment With Stem Cell-Mobilizing Agents Result in Long-Term Kidney Transplant Survival Without Immunosuppression: A Study in Rats.

Authors:  X Hu; T Okabayashi; A M Cameron; Y Wang; M Hisada; J Li; L C Raccusen; Q Zheng; R A Montgomery; G M Williams; Z Sun
Journal:  Am J Transplant       Date:  2016-02-26       Impact factor: 8.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.